Sort
40,608 grants matching “prostate cancer”
Magnetic Resonance Elastography
$341,058Richard L. Ehman · Mayo Clinic Rochester · R01 · FY2012 · EB
Magnetic Resonance Elastography
$341,058Richard L. Ehman · Mayo Clinic Rochester · R01 · FY2011 · EB
Role of Selenium in Development and Health
$340,909Dolph Hatfield · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Targeting the DNA Damage Repair Pathway in Non-Castrate Prostate Cancers
$340,907Howard I Scher · Sloan-Kettering Inst Can Research · P01 · FY2022 · CA
Targeting the DNA Damage Repair Pathway in Non-Castrate Prostate Cancers
$340,907Howard I Scher · Sloan-Kettering Inst Can Research · P01 · FY2023 · CA
Cooperative steroidogenic inhibition for treatment of advanced prostate cancer
$340,899Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2013 · CA
Molecular Design for Specific Recognition of Functional DNA Sequences
$340,875W David Wilson · Georgia State University · R01 · FY2020 · GM
MECHANISMS OF RADIOSENSITIZATION BY THE NEUROTENSIN RECEPTOR ANTAGONIST SR48692 IN PROSTATE CANCER MODELS
$340,875Rector & Visitors Of The University Of Virginia · · FY2008 · Department of the Army
GPR30 and Hepatic Cholesterol Homeostasis
$340,875David Q Wang · Saint Louis University · R01 · FY2016 · DK
GPR30 and Hepatic Cholesterol Homeostasis
$340,875David Q Wang · Saint Louis University · R01 · FY2015 · DK
Molecular Design for Specific Recognition of Functional DNA Sequences
$340,875W David Wilson · Georgia State University · R01 · FY2021 · GM
VALIDATION OF YAP AS A THERAPEUTIC TARGET IN PROSTATE CANCER
$340,875The Leland Stanford Junior University · · FY2014 · Department of Defense
Molecular Design for Specific Recognition of Functional DNA Sequences
$340,875W David Wilson · Georgia State University · R01 · FY2019 · GM
Molecularly Engineered Constructs for anti-CD20 Directed Therapeutics
$340,858Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P50 · FY2008 · CA
TARGETING SURVIVIN WITH APTAMER-SIRNA CHIMERAS FOR THE TREATMENT OF METASTATIC PROSTATE CANCER
$340,836Augusta University Research Institute, Inc · · FY2015 · Department of the Army
Nuclear Neuropilin2: a novel molecular mediator for aggressive Prostate Cancer
$340,803Kaustubh Datta · University Of Nebraska Medical Center · R01 · FY2022 · CA
Nuclear Neuropilin2: a novel molecular mediator for aggressive Prostate Cancer
$340,803Kaustubh Datta · University Of Nebraska Medical Center · R01 · FY2023 · CA
Therapeutic Inhibition of Bcl-2 and Head & Neck Tumor Angiogenesis
$340,794Jacques Eduardo Nor · University Of Michigan At Ann Arbor · R01 · FY2007 · DE
A CLINICAL TRIAL WITH FINASTERIDE AND SELENIUM
$340,785James Marshall · Roswell Park Cancer Institute Corp · P01 · FY2010 · CA
Improving biospecimen quality by verifying adequacy at the point-of-acquisition with ex vivo structured illumination microscopy
$340,785Jonathan Quincy Brown · Tulane University Of Louisiana · R33 · FY2015 · CA
A Precision Medicine Approach to Elucidate Mechanisms of Progression
$340,768Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2018 · CA
The Impact of Aging on Prostate Cancer with Age-Related Disruption of Th17/Treg Axis
$340,746Qiuyang Zhang · Tulane University Of Louisiana · R01 · FY2022 · CA
The Impact of Aging on Prostate Cancer with Age-Related Disruption of Th17/Treg Axis
$340,746Qiuyang Zhang · Tulane University Of Louisiana · R01 · FY2023 · CA
Lipid-dendrimer micellar nanocarriers for siRNA/drug co-delivery in MDR cancer
$340,703Vladimir P Torchilin · Northeastern University · R01 · FY2016 · CA
Core D: Data Management, Biostatistics, and Bioinformatics
$340,692David V Conti · University Of Southern California · U19 · FY2018 · CA